{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:04:41Z","timestamp":1781197481472,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.bbrc.2012.08.042","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T13:46:29Z","timestamp":1345211189000},"page":"94-99","source":"Crossref","is-referenced-by-count":48,"title":["Glycogen synthase kinase-3\u03b2 activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization"],"prefix":"10.1016","volume":"426","author":[{"given":"Haruyuki","family":"Hongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Niidome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hachiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Akaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.08.042_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2012.08.042_b0010","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage","volume":"22","author":"Sherer","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2012.08.042_b0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1097-4547(19970501)48:3<226::AID-JNR5>3.0.CO;2-H","article-title":"MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: an electron microscope study","volume":"48","author":"Sheehan","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2012.08.042_b0020","doi-asserted-by":"crossref","first-page":"34105","DOI":"10.1074\/jbc.M503483200","article-title":"Selective vulnerability of dopaminergic neurons to microtubule depolymerization","volume":"280","author":"Ren","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.08.042_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-4827(74)90210-9","article-title":"Rotenone inhibition of spindle microtubule assembly in mammalian cells","volume":"85","author":"Brinkley","year":"1974","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2012.08.042_b0030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0304-4165(78)90315-X","article-title":"Rotenone inhibition of tubulin self-assembly","volume":"543","author":"Marshall","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2012.08.042_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-4159.2010.06924.x","article-title":"Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration","volume":"115","author":"Cartelli","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2012.08.042_b0040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2005.03493.x","article-title":"The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy","volume":"95","author":"H\u00f6glinger","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2012.08.042_b0045","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1096\/fj.06-6092com","article-title":"Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism","volume":"20","author":"Duka","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2012.08.042_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","article-title":"Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia","volume":"225","author":"Wills","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2012.08.042_b0055","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1074\/jbc.M314116200","article-title":"Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.08.042_b0060","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M210432200","article-title":"Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.08.042_b0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bcp.2008.04.010","article-title":"GSK3beta and endoplasmic reticulum stress mediate rotenone-induced death of SK-N-MC neuroblastoma cells","volume":"76","author":"Chen","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.08.042_b0070","doi-asserted-by":"crossref","first-page":"15469","DOI":"10.1074\/jbc.M707238200","article-title":"Differential modulation of Akt\/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses","volume":"283","author":"Nair","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"Pt 6","key":"10.1016\/j.bbrc.2012.08.042_b0075","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1242\/jcs.109.6.1537","article-title":"Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation","volume":"109","author":"Wagner","year":"1996","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2012.08.042_b0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)03005-0","article-title":"Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium","volume":"919","author":"King","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2012.08.042_b0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2006.03.076","article-title":"Cytoprotection by lithium and valproate varies between cell types and cellular stresses","volume":"539","author":"Lai","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.08.042_b0090","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson\u2019s disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J."},{"issue":"Pt 2","key":"10.1016\/j.bbrc.2012.08.042_b0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj2730481","article-title":"Evidence that the inhibition sites of the neurotoxic amine 1-methyl-4-phenylpyridinium (MPP+) and of the respiratory chain inhibitor piericidin A are the same","volume":"273","author":"Ramsay","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2012.08.042_b0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrd2959","article-title":"Advances in tau-focused drug discovery for Alzheimer\u2019s disease and related tauopathies","volume":"8","author":"Brunden","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2012.08.042_b0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1042\/BST0380977","article-title":"Tau phosphorylation in hippocampus results in toxic gain-of-function","volume":"38","author":"Avila","year":"2010","journal-title":"Biochem. Soc. Trans."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12015525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12015525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T19:31:51Z","timestamp":1643225511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12015525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0006291X12015525"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.08.042","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}